ARCHIVES

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

This article is from The Cancer Letter archive.

Vol. 34 No. 33 | September 12, 2008

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Georgetown Names Cullen Interim Center Director.

November 3, 2000

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

March 2, 2012

ACCC Honors Hammond, Murphy

October 19, 2001

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997